Ionis investor day
Web23 dec. 2024 · Ionis Pharmaceuticals, Inc., is headquartered in Carlsbad, California, with offices in Boston, Massachusetts, and Dublin, Ireland. For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with our novel antisense technology. Ionis currently has three marketed … Web10 apr. 2024 · The company’s 50 day moving average is $36.78 and its two-hundred day moving average is $39.86. Ionis Pharmaceuticals, Inc. has a 12 month low of $31.46 and a 12 month high of $48.82.
Ionis investor day
Did you know?
Web8 apr. 2024 · SPINRAZA, partnered with Biogen ( BIIB) responsible for commercializing SPINRAZA worldwide, is the global market leader in treatment of spinal muscular atrophy [SMA]; through December 31, 2024... Web22 feb. 2024 · As of December 31, 2024, Ionis had cash, cash equivalents and short-term investments of $2.0 billion compared to $2.1 billion at December 31, 2024. Ionis' year …
Web11 apr. 2024 · In the last 3 months, 10 analysts have offered 12-month price targets for Ionis Pharmaceuticals. The company has an average price target of $46.1 with a high of $67.00 and a low of $27.00. Web4 apr. 2024 · Overview. Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes.
WebInvestor relations; Talent; ... SAVINGS DEADLINE EXPIRES IN: 00. Days. 00. Hrs. 00. Mins. 00. Secs. Delivered as Hybrid Event from 30 Oct - 1 Nov 2024. Live In-Person Conference Delivered 30 Oct -1 Nov Amsterdam. Home home; Sponsors. ... Ionis Pharmaceuticals. Patrick Baumhof, PhD. Senior Vice President Technology. CureVac AG. Web9 aug. 2024 · Ionis Pharmaceuticals kept its 2024 outlook intact Tuesday despite a broad second-quarter miss. But IONS stock tumbled. The guidance stayed intact despite a …
WebIONIS PHARMACEUTICALS, INC. : News, Nachrichten und Informationen Aktie IONIS PHARMACEUTICALS, INC. IONS US4622221004 Nasdaq
Web14 apr. 2024 · Finance. Industry. Market ready or not film age ratingWeb28 feb. 2024 · Feb 28, 2024. Ionis to present at upcoming investor conferences. Feb 22, 2024. Ionis reports fourth quarter and full year 2024 financial results. Feb 21, 2024. … ready or not filme legendadoWeb12 apr. 2024 · Get a real-time Ionis Pharmaceuticals, Inc. (IONS) stock price quote with breaking news, financials, ... Ionis to present at upcoming investor conferences. CARLSBAD, Calif. , March 28, 2024 /PRNewswire/ ... reported earnings 30 days ago. What's next for the stock? 4 months ago - Zacks Investment Research. ready or not fling trainerWeb9 dec. 2024 · 2024 Investor Day December 9, 2024 Nasdaq: IONS 2024 INVESTOR DAY Participating in Today's Presentation There will be one Q&A session at the end of today's … how to take care of lavender plantsWebIONIS PHARMACEUTICALS, INC. : Veränderung des Consensus und Kursziel der Analysten der Aktie IONIS PHARMACEUTICALS, INC. IONS US4622221004 Berne Stock Exchange how to take care of lavender bushWeb11 apr. 2024 · Morgan Stanley bestätigt seine Meinung zu den Aktien und bleibt neutral. Zuvor auf 40 USD festgelegt, wurde der Zielpreis auf 42 USD angehoben. 13 April 2024 ready or not flashlight not workingWeb9 nov. 2024 · CARLSBAD, Calif., Nov. 9, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in antisense therapeutics, today announced that … how to take care of lawn in early spring